Evaluation of Safety of a Vaccine Against Cervical Cancer in Healthy Korean Females

Subjects will receive three doses of the Cervarix vaccine administered intramuscularly according to a 0, 1, 6 month vaccination schedule in routine clinical practice settings.

All adverse events will be recorded by all subjects or the subject's parents/guardians using diary cards.